Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Healthcare experts propose concrete steps for managing shortages of life-saving drugs

A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.

4 Feb 2014

Researchers investigate challenges involved with robots working in manufacturing plants, homes

Two researchers in the pioneering Robotics Engineering Program at Worcester Polytechnic Institute (WPI) have received awards through the National Science Foundation's (NSF) National Robotics Initiative to investigate and overcome fundamental challenges involved with robots working alongside people in settings such as manufacturing plants and the homes of the elderly.

4 Feb 2014

Finding could lead to new treatments for osteoporosis

Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth. The finding could lead to new treatments for osteoporosis and other diseases that occur when the body doesn't make enough bone.

31 Jan 2014

Zimmer Holdings fourth quarter net sales increase 5.1% to $1.24 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2013. The Company reported fourth quarter net sales of $1.24 billion, an increase of 5.1% reported and 6.6% constant currency over the fourth quarter of 2012.

30 Jan 2014

Thermo Fisher Scientific fourth quarter revenue increases 6% to $3.47 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2013.

30 Jan 2014

Singapore to become a major hub in Asia for food and nutrition research

The Clinical Nutrition Research Centre - a $20 million joint-venture by the Agency for Science, Technology and Research and National University Health Systems - is the most comprehensive centre in Asia that will conduct nutritional studies to understand the causes of metabolic diseases such as diabetes and obesity, and develop products and formulate diets that can reduce the risks of these diseases. CNRC will also conduct studies in research areas such as nutrition in women, children and the elderly, and body weight control.

30 Jan 2014

Polymer Technology signs agreement to supply CardioChek PA test system to Workwell Consultants

Polymer Technology Systems, Inc., the U.S.-based manufacturer of the CardioChek® family of point-of-care diagnostic products and Whitmire Medical have announced the signing of an agreement to supply the CardioChek PA test system to Workwell Consultants as part of its ongoing effort to create healthier workplaces.

28 Jan 2014

Medac Pharma announces FDA acceptance of New Drug Application for MPI-2505

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced the FDA acceptance of its New Drug Application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection device, for which the proposed indications are rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis.

28 Jan 2014

Remarkable properties of new, porous material could lead to advances in microscopic sponging

The sponges of the future will do more than clean house. Picture this, for example: Doctors use a tiny sponge to soak up a drug and deliver it directly to a tumor. Chemists at a manufacturing plant use another to trap and store unwanted gases.

28 Jan 2014

Polymer Group signs definitive agreement to purchase controlling interest in Providencia

Polymer Group, Inc. today announced that it has signed a definitive agreement to acquire a controlling interest in Companhia Providencia Industria e Comercio, a Brazilian manufacturer of nonwovens used in hygiene, healthcare and industrial applications.

27 Jan 2014

New Chromatrap Enzymatic Shearing Kit announced by Porvair Sciences

Porvair Sciences has announced a new Chromatrap Enzymatic Shearing Kit that contains all the necessary reagents and buffers for up to 10 chromatin preparations.

From Chromatrap® - Porvair Sciences Ltd 27 Jan 2014

NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.

NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.

27 Jan 2014

Study explores potential of antibody-drug conjugates and challenges in manufacturing them

After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.

27 Jan 2014

NIBIO signs collaboration agreement for clinical development of new mucosal TB vaccines

Japan's National Institute of Biomedical Innovation ("NIBIO"), Aeras and Create Vaccine Company, Ltd ("CREATE") announce today that they signed a collaboration agreement on December 26, 2013, on the preclinical and clinical development of new mucosal tuberculosis (TB) vaccines based on NIBIO's human parainfluenza type-2 (rhPIV2) vector technology.

27 Jan 2014

Most high-risk CV devices approved without clinical data

Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective based on approval of prior versions of the device, according to a study in the January 22/29 issue of JAMA.

From Medtronic 27 Jan 2014

Cantrell Drug Company amends FDA registration to include 503B compounding outsourcing facility

Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.

25 Jan 2014

Actavis signs agreement with Zhejiang Chiral to acquire Actavis Foshan, China

Actavis plc today announced that it has signed and completed an agreement for Zhejiang Chiral Medicine Chemicals Co., Ltd to acquire Actavis' interest in Actavis (Foshan) Pharmaceuticals Co., Ltd., an Actavis subsidiary based in Foshan, China.

25 Jan 2014

Scientists aim to develop business plan to guide drug development for potential use in patients

What if an experimental treatment for an aggressive breast cancer had the potential to save women's lives, but nobody could use it because there was no money to develop and test it? With funding sources for research and development more scarce than in the past, it is not an unusual situation. It's a problem that Sourav Sinha, a Master's degree candidate at Rutgers' Graduate School of Biomedical Sciences, is working to tackle head-on.

24 Jan 2014

Covidien announces financial results for first quarter of fiscal 2014

Covidien plc today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of $2.64 billion increased 3% from the $2.57 billion in the first quarter a year ago. Operational sales growth in the quarter was 5%, as foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points.

24 Jan 2014

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety of aldoxorubicin for HIV-infected patients with Kaposi's sarcoma.

23 Jan 2014

Manufacturing News and Research

Further Reading

Healthcare experts propose concrete steps for managing shortages of life-saving drugs

Researchers investigate challenges involved with robots working in manufacturing plants, homes

Finding could lead to new treatments for osteoporosis

Zimmer Holdings fourth quarter net sales increase 5.1% to $1.24 billion

Thermo Fisher Scientific fourth quarter revenue increases 6% to $3.47 billion

Singapore to become a major hub in Asia for food and nutrition research

Polymer Technology signs agreement to supply CardioChek PA test system to Workwell Consultants

Medac Pharma announces FDA acceptance of New Drug Application for MPI-2505

Remarkable properties of new, porous material could lead to advances in microscopic sponging

Polymer Group signs definitive agreement to purchase controlling interest in Providencia

New Chromatrap Enzymatic Shearing Kit announced by Porvair Sciences

NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.

Study explores potential of antibody-drug conjugates and challenges in manufacturing them

NIBIO signs collaboration agreement for clinical development of new mucosal TB vaccines

Most high-risk CV devices approved without clinical data

Cantrell Drug Company amends FDA registration to include 503B compounding outsourcing facility

Actavis signs agreement with Zhejiang Chiral to acquire Actavis Foshan, China

Scientists aim to develop business plan to guide drug development for potential use in patients

Covidien announces financial results for first quarter of fiscal 2014

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News